Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pai-neng-da
- Development stage
- Phase 3
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Pai-Neng-Da (PND) is a Chinese patent medicine formulated as an oral capsule containing the panaxadiol saponin component (PDS-C), which is isolated from total saponins of Panax ginseng. It exerts dual effects by promoting hematopoiesis recovery and regulating immunity. Mechanistically, it is believed to stimulate bone marrow function and modulate immune responses. Clinically, Pai-Neng-Da has been studied for the treatment of chronic aplastic anemia (CAA), primary immune thrombocytopenia (ITP), agnogenic leukocytopenia, myelosuppression-induced hemocytopenia, and non-alcoholic fatty liver disease (NAFLD). Studies indicate that it can be used alone or in combination with other agents such as andriol or cyclosporine to improve blood counts and clinical symptoms in CAA patients[1][2][3][5][6]. The active ingredient has demonstrated safety in both animal studies and clinical trials.
- Brand names
- Pai-Neng-DaPainengda Capsule
- Other names
- panaxadiol saponins componentpanaxadiol saponin capsule
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)GATA1GATA2MAPK14 (p38 mitogen-activated protein kinase alpha)
Beyond the preview
Go deeper on pai-neng-da.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pai-neng-da.